Vascular Dysfunction

Pipeline Programs↗

Active Trials↗

Companies Involved↗

Vascular Dysfunction is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

56/100

Attrition Rate

33/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

clinical trials

Completed5 · 42%

Terminated3 · 25%

Recruiting2 · 17%

Withdrawn1 · 8%

Active, not recruiting1 · 8%

Clinical Trials

Trial Activity

12 trials

Reversing Glucose and Lipid-mediated Vascular Dysfunction

Recruiting·UUniversity of Kansas Medical Center·Phase 1·NCT04832009·46 enrolled

Vascular Disease Discovery Protocol

Recruiting·National Heart, Lung, and Blood Institute (NHLBI)·N/A·NCT03538639·1,000 enrolled

Caveolin-1 and Vascular Dysfunction

Active, not recruiting·—·Phase 1·NCT01426529·120 enrolled

Effect of Salsalate on Bed Rest-Induced Vascular Dysfunction

Completed·—·Phase 1·NCT00553995·60 enrolled

Influence of Dietary Nitrate on Vascular Dysfunction and Inflammation

Completed·QQueen Mary University of London·Phase 1·NCT02715635·78 enrolled

Benfotiamine Prevents Vascular Dysfunction in Healthy Smokers

Completed·RRuhr University of Bochum·Phase 3·NCT00785460·20 enrolled

Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults With ADPKD

Completed·UUniversity of Colorado, Denver·Phase 4·NCT02494141·68 enrolled

Treatment of Exercise-Induced Pulmonary Vascular Dysfunction After Pulmonary Thromboendarterectomy or Balloon Pulmonary Angioplasty

Completed·UUniversity of Colorado, Denver·Phase 2·NCT03409588·10 enrolled

Vascular Dysfunction in Diabetes: Genes and Hormones

Terminated·—·N/A·NCT01511042·100 enrolled

Vascular Dysfunction in Black Individuals: Roles of Nitric Oxide and Endothelin-1

Terminated·UUniversity of Mississippi Medical Center·Phase 1·NCT04770155·8 enrolled

Targeting ER Stress in Vascular Dysfunction

Terminated·—·Phase 1·NCT04001647·17 enrolled

Impact of T Cells on Age-related Vascular Dysfunction: A Translational Approach

Withdrawn·UUniversity of Utah·Phase 1·NCT04344873

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)